Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1993 1
1994 4
1995 3
1998 2
1999 1
2000 1
2001 1
2002 1
2003 2
2004 1
2005 2
2006 1
2007 4
2008 4
2009 1
2010 3
2011 2
2012 4
2013 1
2014 4
2015 4
2016 5
2017 2
2018 4
2019 6
2020 5
2021 2
2022 4
2023 3
2024 5
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura.
Scully M, Cataland SR, Peyvandi F, Coppo P, Knöbl P, Kremer Hovinga JA, Metjian A, de la Rubia J, Pavenski K, Callewaert F, Biswas D, De Winter H, Zeldin RK; HERCULES Investigators. Scully M, et al. N Engl J Med. 2019 Jan 24;380(4):335-346. doi: 10.1056/NEJMoa1806311. Epub 2019 Jan 9. N Engl J Med. 2019. PMID: 30625070 Free article. Clinical Trial.
Evinacumab for Homozygous Familial Hypercholesterolemia.
Raal FJ, Rosenson RS, Reeskamp LF, Hovingh GK, Kastelein JJP, Rubba P, Ali S, Banerjee P, Chan KC, Gipe DA, Khilla N, Pordy R, Weinreich DM, Yancopoulos GD, Zhang Y, Gaudet D; ELIPSE HoFH Investigators. Raal FJ, et al. N Engl J Med. 2020 Aug 20;383(8):711-720. doi: 10.1056/NEJMoa2004215. N Engl J Med. 2020. PMID: 32813947 Clinical Trial.
Visual Outcomes Following Plasma Exchange for Optic Neuritis: An International Multicenter Retrospective Analysis of 395 Optic Neuritis Attacks.
Chen JJ, Flanagan EP, Pittock SJ, Stern NC, Tisavipat N, Bhatti MT, Chodnicki KD, Tajfirouz DA, Jamali S, Kunchok A, Eggenberger ER, Nome MAD, Sotirchos ES, Vasileiou ES, Henderson AD, Arnold AC, Bonelli L, Moss HE, Navarro SEV, Padungkiatsagul T, Stiebel-Kalish H, Lotan I, Wilf-Yarkoni A, Danesh-Meyer H, Ivanov S, Huda S, Forcadela M, Hodge D, Poullin P, Rode J, Papeix C, Saheb S, Boudot de la Motte M, Vignal C, Hacohen Y, Pique J, Maillart E, Deschamps R, Audoin B, Marignier R. Chen JJ, et al. Among authors: poullin p. Am J Ophthalmol. 2023 Aug;252:213-224. doi: 10.1016/j.ajo.2023.02.013. Epub 2023 Feb 21. Am J Ophthalmol. 2023. PMID: 36822570 Free PMC article.
Immunoadsorption and Plasma Exchange are Comparable in Anti-Neutrophil Cytoplasmic Antibodies or Anti-Glomerular Basement Membrane Removal Kinetics.
Sallee M, Resseguier N, Crepin T, Bertin D, Bertrand D, Bobot M, Krummel T, Maillard N, Moussi-Frances J, Pelletier M, Poullin P, Rafat C, Robert T, Terrier B, Rostaing L, Faguer S, Jourde-Chiche N. Sallee M, et al. Among authors: poullin p. Kidney Int Rep. 2024 Jun 27;9(9):2767-2773. doi: 10.1016/j.ekir.2024.06.031. eCollection 2024 Sep. Kidney Int Rep. 2024. PMID: 39291196 Free PMC article.
Anti-ADAMTS13 Antibodies Trajectory is Associated With ADAMTS13 Recovery in Immune-Mediated TTP.
Robert M, Mageau A, Benhamou Y, Provôt F, Fadlallah J, Galicier L, Azoulay E, Ait-Oufella H, Urbina T, Poullin P, Wynckel A, Poulain C, Martis N, Perez P, Rieu V, Delmas Y, Halimi JM, Barbet C, Seguin A, Chatelet V, Augusto JF, Legendre M, Moranne O, Philipponnet C, Cador B, Bouzid R, Joly BS, Veyradier A, Coppo P; French Reference Center for Thrombotic Microangiopathies. Robert M, et al. Among authors: poullin p. Am J Hematol. 2025 Oct;100(10):1736-1746. doi: 10.1002/ajh.70005. Epub 2025 Jul 15. Am J Hematol. 2025. PMID: 40662571 Free PMC article.
Outcomes After Acute Plasma Exchange for Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Thakolwiboon S, Redenbaugh V, Chen B, Hewitt S, Shah S, Lotan I, Levy M, Forcadela M, Huda S, Pique J, Marignier R, Boutiere C, Audoin B, Poullin P, Champsas D, Choi D, Danesh-Meyer HV, Vasileiou E, Sotirchos ES, Davis JB, Henderson AD, Wilf-Yarkoni A, Stiebel-Kalish H, Maillart E, Bonelli L, Arnold AC, Boudot De La Motte M, Deschamps R, Jitprapaikulsan J, Moss HE, Villarreal Navarro SE, Mao-Draayer Y, Mishra M, Vorasoot N, Cacciaguerra L, Tisavipat N, Tajfirouz DA, Tillema JM, Lopez-Chiriboga SA, Palace J, Hacohen Y, Pittock SJ, Flanagan EP, Chen JJ. Thakolwiboon S, et al. Among authors: poullin p. Neurology. 2025 Sep 23;105(6):e213903. doi: 10.1212/WNL.0000000000213903. Epub 2025 Aug 29. Neurology. 2025. PMID: 40882166
Efficacy and Safety of Obinutuzumab in Immune-Mediated Thrombotic Thrombocytopenic Purpura.
Weisinger J, Bouzid R, Fadlallah J, Barbet C, Provot F, Poullin P, Neel A, Marie M, Rieu V, Kanouni T, Moranne O, Azoulay E, Marjanovic Z, Corre E, Joly AC, Baylatry MT, Joly BS, Veyradier A, Coppo P; French National Center for Thrombotic Microangiopathies (CNR‐MAT). Weisinger J, et al. Among authors: poullin p. Am J Hematol. 2025 Feb;100(2):350-353. doi: 10.1002/ajh.27550. Epub 2024 Dec 12. Am J Hematol. 2025. PMID: 39668454 Free PMC article. No abstract available.
80 results